Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8163 |
Intermediate Similarity |
NPD1653 |
Approved |
0.8129 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.8129 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.8027 |
Intermediate Similarity |
NPD1940 |
Clinical (unspecified phase) |
0.791 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.7862 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7806 |
Intermediate Similarity |
NPD919 |
Approved |
0.7756 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7727 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7662 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7643 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7643 |
Intermediate Similarity |
NPD1008 |
Clinical (unspecified phase) |
0.7619 |
Intermediate Similarity |
NPD1652 |
Phase 2 |
0.7595 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7589 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.7574 |
Intermediate Similarity |
NPD3496 |
Discontinued |
0.7571 |
Intermediate Similarity |
NPD3018 |
Phase 2 |
0.7571 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.7561 |
Intermediate Similarity |
NPD7549 |
Discontinued |
0.7556 |
Intermediate Similarity |
NPD5691 |
Approved |
0.7552 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7552 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7535 |
Intermediate Similarity |
NPD1296 |
Phase 2 |
0.7518 |
Intermediate Similarity |
NPD1611 |
Approved |
0.75 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7466 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7464 |
Intermediate Similarity |
NPD2981 |
Phase 2 |
0.7452 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7436 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.7434 |
Intermediate Similarity |
NPD7314 |
Clinical (unspecified phase) |
0.7415 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7413 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.741 |
Intermediate Similarity |
NPD2983 |
Phase 2 |
0.741 |
Intermediate Similarity |
NPD2982 |
Phase 2 |
0.7407 |
Intermediate Similarity |
NPD5536 |
Phase 2 |
0.7407 |
Intermediate Similarity |
NPD7644 |
Approved |
0.7386 |
Intermediate Similarity |
NPD920 |
Approved |
0.7383 |
Intermediate Similarity |
NPD1243 |
Approved |
0.7379 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7372 |
Intermediate Similarity |
NPD4626 |
Approved |
0.7372 |
Intermediate Similarity |
NPD1934 |
Approved |
0.7368 |
Intermediate Similarity |
NPD5283 |
Phase 1 |
0.7333 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7329 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7325 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.7325 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.731 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7308 |
Intermediate Similarity |
NPD1358 |
Approved |
0.7303 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7297 |
Intermediate Similarity |
NPD2796 |
Approved |
0.7293 |
Intermediate Similarity |
NPD5535 |
Approved |
0.7292 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7287 |
Intermediate Similarity |
NPD9697 |
Approved |
0.7278 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7267 |
Intermediate Similarity |
NPD6674 |
Discontinued |
0.7266 |
Intermediate Similarity |
NPD3705 |
Approved |
0.7261 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.7255 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.7255 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7255 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7255 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7255 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7237 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.7233 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7219 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7215 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7195 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.719 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7188 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.7172 |
Intermediate Similarity |
NPD7985 |
Registered |
0.7172 |
Intermediate Similarity |
NPD1699 |
Clinical (unspecified phase) |
0.716 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7153 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7152 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7152 |
Intermediate Similarity |
NPD37 |
Approved |
0.7143 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7143 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7134 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7125 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7125 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7125 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7103 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.7101 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.7099 |
Intermediate Similarity |
NPD3134 |
Approved |
0.7099 |
Intermediate Similarity |
NPD5677 |
Discontinued |
0.7097 |
Intermediate Similarity |
NPD1512 |
Approved |
0.7089 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.7086 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.7078 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7073 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7073 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7073 |
Intermediate Similarity |
NPD5242 |
Approved |
0.7067 |
Intermediate Similarity |
NPD3539 |
Phase 1 |
0.7063 |
Intermediate Similarity |
NPD3267 |
Approved |
0.7063 |
Intermediate Similarity |
NPD2797 |
Approved |
0.7063 |
Intermediate Similarity |
NPD3266 |
Approved |
0.7063 |
Intermediate Similarity |
NPD5353 |
Approved |
0.7059 |
Intermediate Similarity |
NPD5307 |
Clinical (unspecified phase) |
0.7055 |
Intermediate Similarity |
NPD8127 |
Discontinued |
0.7042 |
Intermediate Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.7042 |
Intermediate Similarity |
NPD4749 |
Approved |
0.7039 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7037 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7034 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.7032 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.703 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.703 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.703 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7027 |
Intermediate Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.7027 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7025 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.7021 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.702 |
Intermediate Similarity |
NPD3540 |
Phase 1 |
0.7019 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7007 |
Intermediate Similarity |
NPD6671 |
Approved |
0.7006 |
Intermediate Similarity |
NPD7054 |
Approved |
0.6993 |
Remote Similarity |
NPD8651 |
Approved |
0.6993 |
Remote Similarity |
NPD3225 |
Approved |
0.6981 |
Remote Similarity |
NPD5090 |
Approved |
0.6981 |
Remote Similarity |
NPD5089 |
Approved |
0.698 |
Remote Similarity |
NPD2653 |
Approved |
0.6974 |
Remote Similarity |
NPD2424 |
Discontinued |
0.6968 |
Remote Similarity |
NPD5297 |
Approved |
0.6968 |
Remote Similarity |
NPD4357 |
Discontinued |
0.6966 |
Remote Similarity |
NPD2861 |
Phase 2 |
0.6966 |
Remote Similarity |
NPD2237 |
Approved |
0.6964 |
Remote Similarity |
NPD7472 |
Approved |
0.6964 |
Remote Similarity |
NPD7074 |
Phase 3 |
0.6959 |
Remote Similarity |
NPD4307 |
Phase 2 |
0.6943 |
Remote Similarity |
NPD5403 |
Approved |
0.6939 |
Remote Similarity |
NPD3268 |
Approved |
0.6939 |
Remote Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.6939 |
Remote Similarity |
NPD2313 |
Discontinued |
0.6928 |
Remote Similarity |
NPD2800 |
Approved |
0.6923 |
Remote Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.6923 |
Remote Similarity |
NPD5401 |
Approved |
0.6913 |
Remote Similarity |
NPD4340 |
Discontinued |
0.6908 |
Remote Similarity |
NPD5762 |
Approved |
0.6908 |
Remote Similarity |
NPD5763 |
Approved |
0.6908 |
Remote Similarity |
NPD7266 |
Discontinued |
0.6899 |
Remote Similarity |
NPD3686 |
Approved |
0.6899 |
Remote Similarity |
NPD3687 |
Approved |
0.6894 |
Remote Similarity |
NPD4585 |
Approved |
0.6892 |
Remote Similarity |
NPD6233 |
Phase 2 |
0.6887 |
Remote Similarity |
NPD2799 |
Discontinued |
0.6883 |
Remote Similarity |
NPD7982 |
Clinical (unspecified phase) |
0.6883 |
Remote Similarity |
NPD4110 |
Phase 3 |
0.6883 |
Remote Similarity |
NPD4628 |
Phase 3 |
0.6883 |
Remote Similarity |
NPD4109 |
Clinical (unspecified phase) |
0.6882 |
Remote Similarity |
NPD6559 |
Discontinued |
0.6879 |
Remote Similarity |
NPD1778 |
Approved |
0.6879 |
Remote Similarity |
NPD17 |
Approved |
0.6875 |
Remote Similarity |
NPD6385 |
Approved |
0.6875 |
Remote Similarity |
NPD6386 |
Approved |
0.6875 |
Remote Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.6871 |
Remote Similarity |
NPD7095 |
Approved |
0.6871 |
Remote Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.6866 |
Remote Similarity |
NPD2684 |
Approved |
0.6859 |
Remote Similarity |
NPD7837 |
Clinical (unspecified phase) |
0.6855 |
Remote Similarity |
NPD8158 |
Clinical (unspecified phase) |
0.6855 |
Remote Similarity |
NPD6055 |
Clinical (unspecified phase) |
0.6854 |
Remote Similarity |
NPD6621 |
Clinical (unspecified phase) |
0.6842 |
Remote Similarity |
NPD1551 |
Phase 2 |
0.6842 |
Remote Similarity |
NPD7808 |
Phase 3 |
0.6838 |
Remote Similarity |
NPD228 |
Approved |
0.6824 |
Remote Similarity |
NPD6797 |
Phase 2 |
0.6824 |
Remote Similarity |
NPD6798 |
Discontinued |
0.6821 |
Remote Similarity |
NPD6111 |
Discontinued |
0.6818 |
Remote Similarity |
NPD5698 |
Clinical (unspecified phase) |
0.6815 |
Remote Similarity |
NPD3146 |
Approved |
0.6815 |
Remote Similarity |
NPD3688 |
Clinical (unspecified phase) |
0.6809 |
Remote Similarity |
NPD5585 |
Approved |
0.6807 |
Remote Similarity |
NPD7229 |
Phase 3 |
0.68 |
Remote Similarity |
NPD6355 |
Discontinued |
0.6797 |
Remote Similarity |
NPD1375 |
Discontinued |
0.6797 |
Remote Similarity |
NPD6004 |
Phase 3 |
0.6797 |
Remote Similarity |
NPD6006 |
Clinical (unspecified phase) |
0.6797 |
Remote Similarity |
NPD6005 |
Phase 3 |
0.6797 |
Remote Similarity |
NPD6002 |
Phase 3 |
0.6797 |
Remote Similarity |
NPD2346 |
Discontinued |
0.6797 |
Remote Similarity |
NPD6003 |
Clinical (unspecified phase) |
0.6795 |
Remote Similarity |
NPD7124 |
Phase 2 |
0.6788 |
Remote Similarity |
NPD7843 |
Approved |
0.6784 |
Remote Similarity |
NPD7251 |
Discontinued |
0.6783 |
Remote Similarity |
NPD1091 |
Approved |
0.6781 |
Remote Similarity |
NPD1019 |
Discontinued |
0.6781 |
Remote Similarity |
NPD6917 |
Clinical (unspecified phase) |
0.6776 |
Remote Similarity |
NPD1510 |
Phase 2 |
0.6776 |
Remote Similarity |
NPD4308 |
Phase 3 |
0.6774 |
Remote Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.6772 |
Remote Similarity |
NPD3647 |
Clinical (unspecified phase) |
0.6763 |
Remote Similarity |
NPD7157 |
Approved |
0.6759 |
Remote Similarity |
NPD6696 |
Suspended |
0.6753 |
Remote Similarity |
NPD1549 |
Phase 2 |
0.675 |
Remote Similarity |
NPD3226 |
Approved |
0.6746 |
Remote Similarity |
NPD7228 |
Approved |
0.6739 |
Remote Similarity |
NPD1398 |
Phase 1 |
0.6739 |
Remote Similarity |
NPD1241 |
Discontinued |
0.6736 |
Remote Similarity |
NPD9717 |
Approved |
0.6736
|
Remote Similarity |
NPD1608 |
Approved |